Novo Nordisk announced on March 4, 2024, that its clinical trials for an oral version of the Alzheimer’s drug semaglutide did not succeed in slowing the...
Novo Nordisk has announced a significant price reduction for its weight-loss injection, Wegovy, by up to 37% in India. This strategic decision comes as the Danish...
Pfizer has initiated legal proceedings against Metsera and Novo Nordisk in a Delaware court, following a recent bid by the Danish pharmaceutical company that surpasses Pfizer’s...
